Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 93467175 | 9346717 | 5 | F | 201205 | 20160726 | 20130613 | 20160726 | EXP | JP-BRISTOL-MYERS SQUIBB COMPANY-19010941 | BRISTOL MYERS SQUIBB | 37.73 | YR | M | Y | 90.00000 | KG | 20160726 | CN | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 93467175 | 9346717 | 1 | PS | ABILIFY | ARIPIPRAZOLE | 1 | Oral | 24 MG, QD | Y | 21436 | 24 | MG | TABLET | QD | |||||
| 93467175 | 9346717 | 2 | SS | LIMAS | LITHIUM CARBONATE | 1 | Oral | TABS | U | 0 | 1200 | MG | QD | ||||||
| 93467175 | 9346717 | 3 | SS | LEVOTOMIN | LEVOMEPROMAZINE | 1 | Oral | 125 MG, QD | U | 0 | 125 | MG | QD | ||||||
| 93467175 | 9346717 | 4 | SS | SERTRALINE | SERTRALINE HYDROCHLORIDE | 1 | Unknown | TABS | U | 0 | |||||||||
| 93467175 | 9346717 | 5 | SS | LITHIUM. | LITHIUM | 1 | Unknown | TABS | U | 0 | |||||||||
| 93467175 | 9346717 | 6 | SS | VALPROATE SODIUM. | VALPROATE SODIUM | 1 | Unknown | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 93467175 | 9346717 | 1 | Bipolar disorder |
| 93467175 | 9346717 | 2 | Bipolar disorder |
| 93467175 | 9346717 | 3 | Bipolar disorder |
| 93467175 | 9346717 | 4 | Product used for unknown indication |
| 93467175 | 9346717 | 5 | Product used for unknown indication |
| 93467175 | 9346717 | 6 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 93467175 | 9346717 | OT |
| 93467175 | 9346717 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 93467175 | 9346717 | Agitation | |
| 93467175 | 9346717 | Altered state of consciousness | |
| 93467175 | 9346717 | Blood creatine phosphokinase increased | |
| 93467175 | 9346717 | Dehydration | |
| 93467175 | 9346717 | Dysphagia | |
| 93467175 | 9346717 | Electrocardiogram abnormal | |
| 93467175 | 9346717 | Electroencephalogram abnormal | |
| 93467175 | 9346717 | Gait disturbance | |
| 93467175 | 9346717 | Pneumonia | |
| 93467175 | 9346717 | Renal impairment | |
| 93467175 | 9346717 | Thyroid function test abnormal | |
| 93467175 | 9346717 | Toxicity to various agents |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 93467175 | 9346717 | 1 | 20120426 | 20120515 | 0 | |
| 93467175 | 9346717 | 2 | 20120426 | 20120515 | 0 | |
| 93467175 | 9346717 | 3 | 20120426 | 20120515 | 0 | |
| 93467175 | 9346717 | 6 | 20120426 | 20120515 | 0 |